Anti-inflammatory and antimicrobial properties of some licorice metabolites-Reference-Cited by-同舟云学术

Anti-inflammatory and antimicrobial properties of some licorice metabolites

Published:2024-03-26 Issue:2 Volume: Page:75-88
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:ECG

Author:

Khavkin A. I.¹^ORCID,Nikolaychuk K. M.²^ORCID,Shreiner E. V.³^ORCID,Novikova M. F.²^ORCID,Veremenko A. S.²^ORCID,Levchenko I. D.²^ORCID,Vergunova E. E.²^ORCID,Tumas A. S.²^ORCID,Platonova P. Ya.²^ORCID,Ponomarenko A. V.⁴^ORCID,Pak I. A.⁵^ORCID,Pokushalov E. A.⁵^ORCID

Affiliation:

1. Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region; Belgorod State Research University

2. Novosibirsk State University

3. Novosibirsk State University; Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS; Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory

4. Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS; Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory

5. Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory

Abstract

This article highlights the pharmacological activity of licorice metabolites of significant interest in the context of the treatment of cancer, cardiovascular, and respiratory diseases. The review details the diversity and efficacy of lichalocone, isoliquiritigenin, liquiritigenin, and other licorice metabolites that exhibit anti-inflammatory, antimicrobial, and antioxidant effects. These effects are based on the ability of licorice metabolites to regulate molecular cascades responsible for apoptosis, cell cycle, cell proliferation and many other processes. The article discusses in detail the prospects for the use of licorice metabolites in oncology, cardiology, their potential in the development of new drugs and the need for further research to determine their full therapeutic potential.

Publisher

LLC Global Media Technology

Reference86 articles.

1. Wahab S, Annadurai S, Abullais SS, Das G, Ahmad W, Ahmad MF et al. Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology. Plants (Basel). 2021 Dec 14;10(12):2751. doi: 10.3390/plants10122751.

2. Gaur R, Yadav KS, Verma RK, Yadav NP, Bhakuni RS. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine. 2014 Mar 15;21(4):415-22. doi: 10.1016/j.phymed.2013.10.015.

3. Xiaoying W, Han Z, Yu W. Glycyrrhiza glabra (Licorice): ethnobotany and health benefits. Sustained energy for enhanced human functions and activity. Academic Press. 2017: 231-250. doi: 10.1016/B978-0-12-805413-0.00014-4

4. Alsayari A, Wahab S. Genus Ziziphus for the treatment of chronic inflammatory diseases. Saudi J Biol Sci. 2021 Dec;28(12):6897-6914. doi: 10.1016/j.sjbs.2021.07.076.

5. Bao F, Bai HY, Wu ZR, Yang ZG. Phenolic compounds from cultivated Glycyrrhiza uralensis and their PD-1/PD-L1 inhibitory activities. Nat Prod Res. 2021 Feb;35(4):562-569. doi: 10.1080/14786419.2019.1586698.